Semaglutide is a long-acting glucagon-like peptide-1 receptor (GLP-1R) agonist studied for its effects on glucose-dependent insulin signaling, appetite regulation, gastric emptying, and broader metabolic pathways.
This product is supplied strictly for laboratory and scientific research purposes only. It is not intended for human consumption, medical treatment, diagnostic use, or veterinary applications. Purchasers are responsible for ensuring compliance with all applicable laws and regulations regarding the handling and use of research materials.
Semaglutide is a modified GLP-1 analog designed for prolonged GLP-1 receptor activity. Research has examined its influence on glucose homeostasis, insulin and glucagon signaling, appetite-related pathways, gastric motility, energy metabolism, and downstream metabolic processes involving adipose tissue and lipid regulation.
For a research-use-only catalog, Semaglutide is suitable for research involving:
Purity: ≥98%